AAAAAA
Results: 1-25/51
Authors:
Sarkar, D
Vallance, P
Harding, SE
Citation: D. Sarkar et al., Nitric oxide: not just a negative inotrope, EUR J HE FA, 3(5), 2001, pp. 527-534
Authors:
Vallance, P
Chan, N
Citation: P. Vallance et N. Chan, Endothelial function and nitric oxide: clinical relevance, HEART, 85(3), 2001, pp. 342-350
Authors:
Murray-Rust, J
Leiper, J
McAlister, M
Phelan, J
Tilley, S
Maria, JS
Vallance, P
McDonald, N
Citation: J. Murray-rust et al., Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase (vol 8, pg 679, 2001), NAT ST BIOL, 8(9), 2001, pp. 818-818
Authors:
Murray-Rust, J
Leiper, J
McAlister, M
Phelan, J
Tilley, S
Maria, JS
Vallance, P
McDonald, N
Citation: J. Murray-rust et al., Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase, NAT ST BIOL, 8(8), 2001, pp. 679-683
Authors:
Chan, NN
Colhoun, HN
Vallance, P
Citation: Nn. Chan et al., Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population, J AM COL C, 38(7), 2001, pp. 1814-1820
Authors:
Grahame-Clarke, C
Alber, DG
Lucas, SB
Miller, R
Vallance, P
Citation: C. Grahame-clarke et al., Association between Kaposi's sarcoma and atherosclerosis: implications forgammaherpesviruses and vascular disease, AIDS, 15(14), 2001, pp. 1902-1904
Authors:
Jeerooburkhan, N
Jones, LC
Bujac, S
Cooper, JA
Miller, GJ
Vallance, P
Humphries, SE
Hingorani, AD
Citation: N. Jeerooburkhan et al., Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease, HYPERTENSIO, 38(5), 2001, pp. 1054-1061
Authors:
Vallance, P
Citation: P. Vallance, The asymmetrical dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in the regulation of nitric oxide generation - Comment, CLIN SCI, 100(2), 2001, pp. 159-160
Authors:
Kharbanda, R
Vallance, P
Citation: R. Kharbanda et P. Vallance, Coronary artery disease - from bench to bedside, J ROY S MED, 94(2), 2001, pp. 61-64
Authors:
Vallance, P
Citation: P. Vallance, Biotechnology and new companies arising from academia, LANCET, 358(9295), 2001, pp. 1804-1806
Authors:
Vallance, P
Citation: P. Vallance, Releasing the grip of big pharma, LANCET, 358(9282), 2001, pp. 664-664
Authors:
Vallance, P
Citation: P. Vallance, Taking risks: primary prevention of cardiovascular events, NZ MED J, 114(1132), 2001, pp. 223-224
Authors:
Chan, NN
MacAllister, RJ
Colhoun, HM
Vallance, P
Hingorani, AD
Citation: Nn. Chan et al., Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women, J CLIN END, 86(6), 2001, pp. 2499-2504
Authors:
Mullen, MJ
Kharbanda, RK
Cross, J
Donald, AE
Taylor, M
Vallance, P
Deanfield, JE
MacAllister, RJ
Citation: Mj. Mullen et al., Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo - Relevance to endothelial dysfunction in hypercholesterolemia, CIRCUL RES, 88(2), 2001, pp. 145-151
Authors:
Kharbanda, RK
Peters, M
Walton, B
Kattenhorn, M
Mullen, M
Klein, N
Vallance, P
Deanfield, J
MacAllister, R
Citation: Rk. Kharbanda et al., Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo, CIRCULATION, 103(12), 2001, pp. 1624-1630
Authors:
Vallance, P
Hingorani, AD
Ulrich, S
Citation: P. Vallance et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age - Reply, BR MED J, 321(7261), 2000, pp. 638-638
Authors:
Ulrich, S
Hingorani, AD
Martin, J
Vallance, P
Citation: S. Ulrich et al., What is the optimal age for starting lipid lowering treatment? A mathematical model, BR MED J, 320(7242), 2000, pp. 1134-1140
Authors:
Tran, CTL
Fox, MF
Vallance, P
Leiper, JM
Citation: Ctl. Tran et al., Chromosomal localization, gene structure, and expression pattern of DDAH1:Comparison with DDAH2 and implications for evolutionary origins, GENOMICS, 68(1), 2000, pp. 101-105
Authors:
White, RP
Vallance, P
Markus, HS
Citation: Rp. White et al., Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans, CLIN SCI, 99(6), 2000, pp. 555-560
Authors:
Vallance, P
Rees, D
Moncada, S
Citation: P. Vallance et al., Therapeutic potential of NOS inhibitors in septic shock, HANDB EXP P, 143, 2000, pp. 385-397
Authors:
White, RP
Deane, C
Hindley, C
Bloomfield, PM
Cunningham, VJ
Vallance, P
Brooks, DJ
Markus, HS
Citation: Rp. White et al., The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man, J NEUR SCI, 178(1), 2000, pp. 23-28
Authors:
Chan, NN
Vallance, P
Colhoun, HM
Citation: Nn. Chan et al., Nitric oxide and vascular responses in Type I diabetes, DIABETOLOG, 43(2), 2000, pp. 137-147
Authors:
Hingorani, AD
Cross, J
Kharbanda, RK
Mullen, MJ
Bhagat, K
Taylor, M
Donald, AE
Palacios, M
Griffin, GE
Deanfield, JE
MacAllister, RJ
Vallance, P
Citation: Ad. Hingorani et al., Acute systemic inflammation impairs endothelium-dependent dilatation in humans, CIRCULATION, 102(9), 2000, pp. 994-999
Authors:
Alber, DG
Powell, KL
Vallance, P
Goodwin, DA
Grahame-Clarke, C
Citation: Dg. Alber et al., Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse, CIRCULATION, 102(7), 2000, pp. 779-785
Authors:
Sarkar, D
Vallance, P
Amirmansour, C
Harding, SE
Citation: D. Sarkar et al., Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides, CARDIO RES, 48(3), 2000, pp. 430-439